Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.

Evaluates novel aldosterone-lowering therapies as next-generation treatments for resistant hypertension and cardiorenal protection in patients with CKD.